Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

R&G PharmaStudies Co., Ltd. (301333.SZ)

44.46
+0.20
+(0.45%)
As of 9:25:01 AM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Jie Wu M.B.A. Chairman & GM -- -- 1961
Ms. Qian Zhao Chief Financial Officer -- -- 1984
Ms. Leyan Teng COO, Senior VP & Director -- -- 1972
Dr. Gang Chen Deputy GM & Chief Scientific Officer -- -- 1956
Mr. Wei Wang EMBA Deputy GM & Director -- -- 1978
Mr. Jigang Li M.B.A. Senior VP & Chief Medical Officer -- -- 1973
Dr. Ping Liu General Manager of Lingchu Pharmaceutical Technology Co., Ltd. -- -- --
Dr. Shuqi Li Senior VP, Board Secretary & Director -- -- 1965

R&G PharmaStudies Co., Ltd.

North Tower, Block B
Floor 11, Huatong Building, No. 19 Chegongzhuang West Road Haidian District
Beijing, 100048
China
https://www.rg-pharma.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
2,208

Description

R&G PharmaStudies Co., Ltd. provides clinical research outsourcing services for pharmaceutical and medical device companies, and scientific research institutions in China. It offers clinical trial consulting, clinical trial operation, data management and statistical analysis, technical services and solutions, biostatistical quantitative scientific support, and various services related to the clinical trial data monitoring committee, including participating in the committee or relevant statistical analysis for the committee. The company also provides clinical pharmacology services; biological sample testing services to analyze and detect the biological samples collected during the clinical trial, and to determine the concentration of the original drug and/or metabolites; and clinical trial site management services. The company was founded in 2008 and is based in Beijing, China.

Corporate Governance

R&G PharmaStudies Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 5, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers